187 related articles for article (PubMed ID: 35784552)
1. Altered Caffeine Metabolism Is Associated With Recurrent Hypoglycemia in Type 2 Diabetes Mellitus: A UPLC-MS-Based Untargeted Metabolomics Study.
Lijing W; Sujie K; Linxi W; Lishan H; Liqin Q; Zhidong Z; Kejun W; Mengjun Z; Xiaoying L; Xiaohong L; Libin L
Front Endocrinol (Lausanne); 2022; 13():843556. PubMed ID: 35784552
[TBL] [Abstract][Full Text] [Related]
2. LC-MS-Based Untargeted Metabolomics Reveals Early Biomarkers in STZ-Induced Diabetic Rats With Cognitive Impairment.
Chen R; Zeng Y; Xiao W; Zhang L; Shu Y
Front Endocrinol (Lausanne); 2021; 12():665309. PubMed ID: 34276557
[TBL] [Abstract][Full Text] [Related]
3. Altered neopterin and IDO in kynurenine metabolism based on LC-MS/MS metabolomics study: Novel therapeutic checkpoints for type 2 diabetes mellitus.
Liu Z; Ma Z; Jin L; Nizhamuding X; Zeng J; Zhang T; Zhang J; Wang J; Zhao H; Zhou W; Zhang C
Clin Chim Acta; 2024 Apr; 557():117859. PubMed ID: 38518968
[TBL] [Abstract][Full Text] [Related]
4. LC-MS-based untargeted metabolomics reveals the mechanism underlying prostate damage in a type 2 diabetes mouse model.
Qi R; Kang SS; Pei Y; Liu M; Zhou Y; Guan B; Zhang X; Li Z; Cao F
Reprod Biol; 2023 Dec; 23(4):100811. PubMed ID: 37660522
[TBL] [Abstract][Full Text] [Related]
5. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
Guo M; Zhang J
Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
[TBL] [Abstract][Full Text] [Related]
6. [Metabolomics study of Danggui Buxue Tang on treatment of type 2 diabetes mice using UHPLC-Q-TOF-MS].
Sun LL; Bai HY; Zheng WH; Wang LY; Zhao W; Li JY; Shi YB; Yang ZG
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):636-644. PubMed ID: 32237524
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes of serum metabolite profiling in septic mice based on high performance liquid chromatography of quadrupole time of flight mass spectrometry analysis.
Li S; Zeng Q; Li S; Liu Y; Feng Y; Chen F; Zou L; Liu X; Liu Y; Jiang Y
Eur J Mass Spectrom (Chichester); 2023 Jun; 29(3):159-169. PubMed ID: 37338428
[TBL] [Abstract][Full Text] [Related]
8. [Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry].
Ma Z; Li Z; Wang H; Wang R; Han X
Se Pu; 2022 Jun; 40(6):541-546. PubMed ID: 35616199
[TBL] [Abstract][Full Text] [Related]
9. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
10. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
[TBL] [Abstract][Full Text] [Related]
11. Altered adolescents obesity metabolism is associated with hypertension: a UPLC-MS-based untargeted metabolomics study.
Wu ZP; Wei W; Cheng Y; Chen JY; Liu Y; Liu S; Hu MD; Zhao H; Li XF; Chen X
Front Endocrinol (Lausanne); 2023; 14():1172290. PubMed ID: 37229452
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF/MS.
Zhong Z; Huang Y; Huang Q; Zheng S; Huang Z; Deng W; Li T
Clin Chim Acta; 2021 Apr; 515():52-60. PubMed ID: 33388309
[TBL] [Abstract][Full Text] [Related]
13. Salivary metabolomics of burning mouth syndrome: A cross-sectional study.
Ye L; Dai Q; Hou F; Wu C; Qiu X; Yuan P; Chen F; Meng Y; Feng X; Jiang L
Arch Oral Biol; 2022 Dec; 144():105552. PubMed ID: 36279827
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of metabolite differences in skin between Clapp's Favorite and its mutant Red Clapp's Favorite through non-targeted metabolomics].
Mu H; Ci Z; Aisajan M; Liang Y; Liu X; DU X; Yu Q; Li Q; Li Y
Se Pu; 2021 Nov; 39(11):1203-1212. PubMed ID: 34677015
[TBL] [Abstract][Full Text] [Related]
15. Metabolite profiling analysis of hepatitis B virus-induced liver cirrhosis patients with minimal hepatic encephalopathy using gas chromatography-time-of-flight mass spectrometry and ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
Huang G; Xie S; Wang M; Mao D; Huang G; Huang J; Liu X; Zhang R; Xie J; Huang LJ; Cheng C; Yao F; Zhong Y; Lin L; Yao C
Biomed Chromatogr; 2023 Jan; 37(1):e5529. PubMed ID: 36250932
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
[TBL] [Abstract][Full Text] [Related]
17. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
[No Abstract] [Full Text] [Related]
18. Lipidomics study of plasma phospholipid metabolism in early type 2 diabetes rats with ancient prescription Huang-Qi-San intervention by UPLC/Q-TOF-MS and correlation coefficient.
Wu X; Zhu JC; Zhang Y; Li WM; Rong XL; Feng YF
Chem Biol Interact; 2016 Aug; 256():71-84. PubMed ID: 27369808
[TBL] [Abstract][Full Text] [Related]
19. Serum metabonomics of NAFLD plus T2DM based on liquid chromatography-mass spectrometry.
Chen Y; Li C; Liu L; Guo F; Li S; Huang L; Sun C; Feng R
Clin Biochem; 2016 Sep; 49(13-14):962-6. PubMed ID: 27211699
[TBL] [Abstract][Full Text] [Related]
20. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
